The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116507543 11650754 3 F 20130904 20160915 20151021 20160926 EXP JP-ALEXION-A201401745 ALEXION 72.00 YR M Y 56.00000 KG 20160926 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116507543 11650754 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600-300 MG, QW Y 125166 CONCENTRATE FOR SOLUTION FOR INFUSION /wk
116507543 11650754 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, Q2W Y AA8793B02 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
116507543 11650754 3 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, SINGLE Y AA8793B02 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
116507543 11650754 4 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 300 MG, SINGLE Y 125166 300 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
116507543 11650754 5 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W Y 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
116507543 11650754 6 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, Q2W Y 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
116507543 11650754 7 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 300 MG, Q2W Y AD6547B01 125166 300 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
116507543 11650754 8 SS PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Unknown 20 MG, DAILY Y 0 20 MG QD
116507543 11650754 9 SS PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Unknown 15-7MG, DAILY Y 0 QD
116507543 11650754 10 SS PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 7-1 MG DAILY Y 0
116507543 11650754 11 C NEORAL CYCLOSPORINE 1 Oral 50 MG, UNK 0 50 MG
116507543 11650754 12 C NEORAL CYCLOSPORINE 1 Oral 40 MG, UNK 0 40 MG
116507543 11650754 13 C NEORAL CYCLOSPORINE 1 Oral 200 MG, QD 0 200 MG QD
116507543 11650754 14 C NESP DARBEPOETIN ALFA 1 Intravenous (not otherwise specified) 120 ?G, Q2W 0 120 UG INJECTION QOW
116507543 11650754 15 C BUFFERIN /00009201/ ASPIRINDIHYDROXYALUMINUM AMINOACETATE ANHYDROUSMAGNESIUM CARBONATE 1 Intravenous (not otherwise specified) 81 MG, DAILY 0 81 MG INJECTION
116507543 11650754 16 C MICARDIS TELMISARTAN 1 Oral 20 MG, DAILY 0 20 MG
116507543 11650754 17 C BAKTAR SULFAMETHOXAZOLETRIMETHOPRIM 1 Unknown 1 G, TIW 0 1 G TIW
116507543 11650754 18 C FEBURIC FEBUXOSTAT 1 Unknown 10-20 MG, DAILY 0
116507543 11650754 19 C PARIET RABEPRAZOLE SODIUM 1 Oral 10 MG, DAILY 0 10 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116507543 11650754 1 Paroxysmal nocturnal haemoglobinuria
116507543 11650754 8 Haemolysis
116507543 11650754 11 Paroxysmal nocturnal haemoglobinuria
116507543 11650754 14 Paroxysmal nocturnal haemoglobinuria
116507543 11650754 15 Paroxysmal nocturnal haemoglobinuria
116507543 11650754 16 Product used for unknown indication
116507543 11650754 17 Product used for unknown indication
116507543 11650754 18 Product used for unknown indication
116507543 11650754 19 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
116507543 11650754 LT
116507543 11650754 HO
116507543 11650754 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
116507543 11650754 Acute myeloid leukaemia
116507543 11650754 Anaemia
116507543 11650754 Diabetes mellitus
116507543 11650754 Drug ineffective
116507543 11650754 Gastrointestinal haemorrhage
116507543 11650754 Haemolysis
116507543 11650754 Inappropriate schedule of drug administration
116507543 11650754 Incorrect dose administered
116507543 11650754 Platelet count decreased
116507543 11650754 Renal failure
116507543 11650754 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116507543 11650754 1 20130904 20131002 0
116507543 11650754 2 20131009 20140423 0
116507543 11650754 3 20140507 20140507 0
116507543 11650754 4 20140508 20140508 0
116507543 11650754 5 20140521 20150814 0
116507543 11650754 6 20150828 20150925 0
116507543 11650754 7 20151009 20151023 0
116507543 11650754 8 20140507 20140514 0
116507543 11650754 9 20140515 0
116507543 11650754 11 200801 0
116507543 11650754 13 20160112 0
116507543 11650754 14 20130422 20151225 0
116507543 11650754 15 20120924 20150925 0
116507543 11650754 16 20130903 20151211 0
116507543 11650754 17 200810 0
116507543 11650754 18 20130927 0
116507543 11650754 19 20150408 0